Client Result
Orrick Advised Catalyst Biosciences on $60 Million Sale of Complement Portfolio
May.24.2022

Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
May.24.2022
May.24.2022
May.23.2022
Orrick advised DIF Core Infrastructure Fund I on the sale of its majority stake in ADTIM SAS to HICL Infrastructure PLC.
May.19.2022
May.19.2022
May.19.2022
May.17.2022
We advised Baidu, Inc. on the sale of its Aladdin business to XGIMI.
May.13.2022
May.12.2022
May.10.2022
May.03.2022